ロード中...
Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
We treated patients under age 50 years with (131)I-anti-CD45 antibody combined with fludarabine and 2 Gy total body irradiation to create an improved hematopoietic cell transplantation (HCT) strategy for advanced acute myeloid leukemia or high-risk myelodysplastic syndrome patients. Fifteen patients...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4127337/ https://ncbi.nlm.nih.gov/pubmed/24858425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.05.014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|